Business Analyst - Mediterranean Cluster, Rare Diseases, Eu & International
Chiesi Farmaceutici · Parma, Provincia di Parma
Job Description
Business Analyst - Mediterranean Cluster, Rare Diseases
Company: Chiesi Farmaceutici Location: Parma, Italy Contract: Permanent Work Model: Onsite
About Chiesi Farmaceutici
Chiesi is an international research-focused pharmaceutical and healthcare group with 90 years of experience. Based in Parma, Italy, the company operates in 31 countries and employs over 7,000 people. Chiesi is dedicated to improving people's quality of life by acting responsibly towards society.
About the Role
This is a mid-level, permanent, onsite position within the Rare Mediterranean Business Unit. You will play a crucial role in supporting the Marketing, Market Access, Business Excellence, and Medical Affairs functions within the Rare Diseases therapeutic area.
Key Responsibilities
- Analyze business needs and translate them into actionable insights and solutions.
- Support market access strategies for rare disease products within the Mediterranean cluster.
- Contribute to business excellence initiatives to optimize operations and performance.
- Collaborate with Medical Affairs teams to ensure alignment and support for medical strategies.
- Gather and interpret data to inform decision-making and drive business growth.
Requirements
- Proven experience as a Business Analyst.
- Knowledge of the Rare Diseases therapeutic area.
- Familiarity with Market Access principles.
- Experience in Business Excellence methodologies.
- Understanding of Medical Affairs operations.
- Strong analytical and problem-solving skills.
- Excellent communication and interpersonal abilities.
What We Offer
- A permanent contract with a leading international pharmaceutical company.
- The opportunity to work in the dynamic field of Rare Diseases.
- A collaborative and supportive work environment in Parma, Italy.
- The chance to contribute to improving patient lives.
✨ This description was enhanced by AI based on the original listing.